Crosslink Therapeutics is a startup based in the United States, most recent round Seed.
Based in the United States, Crosslink Therapeutics is a startup. Its most recent tracked round is Seed.
Crosslink Therapeutics develops modular biologic therapeutics that conditionally assemble in the tumor microenvironment by leveraging elevated extracellular ATP in solid tumors to improve targeting and efficacy in cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.